|Bid||74.43 x 800|
|Ask||74.64 x 1400|
|Day's Range||74.26 - 74.93|
|52 Week Range||55.36 - 77.23|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||13.63|
|Earnings Date||May 04, 2021 - May 10, 2021|
|Forward Dividend & Yield||2.00 (2.70%)|
|Ex-Dividend Date||Apr 22, 2021|
|1y Target Est||86.20|
CVS Health (CVS) closed the most recent trading day at $74.46, moving +0.53% from the previous trading session.
The U.S. is facing another surge in new COVID-19 cases in some states, led by Michigan, but the White House has spurned Michigan Gov. Gretchen Whitmer request for corresponding surge in vaccines for her state, even as daily vaccinations hit a record of more than 4.6 million over the weekend.
CVS Health Corp. said Monday that it is adding locations where it administers the COVID-19 vaccination to eligible patients in four states starting April 14: Nebraska, Maine, Arkansas and Iowa. Appointments will become available on April 13. As of April 14, the pharmacy retailer will be administering vaccinations at more than 6,000 locations in 49 states, Puerto Rico and Washington D.C., with 70% of the U.S. population within five miles of a location. CVS, which has the capacity for 25 million vaccinations per month, says that the pace of the shots should increase as supply increases. CVS has said previously that it expects to reach millions of new customers through the COVID-19 vaccination process. CVS stock is up 8.5% for the year to date while the S&P 500 index is up nearly 10% for the period.